Top Toronto, Ontario Biotech Companies (37)

BenchSci’s vision is to bring novel medicine to patients 50% faster by 2025. To achieve this, we're exponentially increasing the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence. Backed by F-Prime, Gradient Ventures (Google’s AI fund), Inovia Capital, and TCV, our platform accelerates science at 16 of the top-20 pharmaceutical companies, and...

ProteinQure is a revenue-generating software platform for computational protein drug discovery. We combine molecular simulations, machine learning, and quantum computing to do the structure-based design of drugs. These physics-based methods make us less dependent on large data sets and that allows us to explore novel protein structures and interactions. We use our computational platform (as well as wetlab validation) to...

Geneseeq is a research-driven company providing cutting-edge next-generation sequencing (NGS) technology to accelerate precision cancer care. We offer both pan-cancer panels analyzing 400+ genes and cancer-type-specific gene panels for all sample types to help match a patient to the optimal treatment, including targeted therapy and immunotherapy for solid tumors and blood cancers. Additionally, we develop cutting-edge technologies and kits for...

Pontosense is fundamentally changing technology by expanding the relationship between humans and machines. Our passion for innovation pushes the boundaries of wireless sensing further than ever, leading to global partnerships and applications across several industries, including mobility, Age Tech, and smart homes. Our contactless AI solution uses mmWave RADAR to ensure the safety of your loved ones. It is the only...

Rapid Novor Inc. is the world's leader in antibody protein sequencing technology. Specializing in the field of mass spectrometry-based proteomics, the team has developed the technology to directly sequence antibody proteins without needing to access the producing cell line. As a University of Waterloo spin-off, the company is building its technology portfolios based on the twenty years of scientific research...

Novel Biotechnology is a Synthetic Biology company focused on developing highly productive pDNA manufacturing platform. We also provide CRDMO and plasmid DNA manufacturing services to our clients

Affinity Biologicals, Inc. is a primary manufacturer of products used worldwide in thrombosis and hemostasis research and diagnostics. Our products include an extensive line of antibodies, conjugates, antibody pairs for immunoassay of human and animal analytes, the VisuLize line of complete ELISA kits, and a full line of human plasma products including VisuDep Immune-Depleted Factor-Deficient Plasmas, VisuCal Calibrator Plasma and...

Vital was created to enable proactive, preventative, and accessible healthcare. We're starting with a radically disruptive approach to lab testing. Backed by many years of R&D by world-class scientists and engineers, we are a team of collaborators, re-engineering the nature of care delivery.

Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. Established in 2012, Nicoya was founded by Ryan Denomme in his relentless pursuit to use nanotechnology to increase the affordability and ease of use of scientific instruments. Within 10 years, Nicoya has grown to a team of 100+ employees who have extensive experience working at...

AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications. Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals. We have developed a platform technology which addresses the critical problem of sustaining...

ProteinQure is a biotech company focused on the design of novel exotic peptides with broad therapeutic applications. Powered by atomic-level simulations and artificial intelligence, we design dynamic peptides that take drugs straight to their target – outperforming other treatment delivery systems. By daring to deliver therapeutics in a novel way we are changing the game for drug development and bringing...

For over 240 years, Takeda’s propensity to evolve has driven the next generation of innovation, and as a future-focused organization, we’re continuing to drive forward with endurance in our steadfast pursuit to achieve the best outcomes for our patients in a rapidly changing world.  We have been preparing for this period of value creation by investing in data, digital and...

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.

Toronto-based ​infectious disease intelligence company, BlueDot, has developed a first-of-its-kind, global early warning technology for infectious diseases. Using artificial and human intelligence, BlueDot’s outbreak risk platform tracks over 120 infectious diseases globally in 65 languages, around the clock and anticipates their spread and impact. They empower national and international health agencies, pharma and life sciences companies, and businesses to better...

MedAvail Inc. is the developer of the MedCenter automated dispensing and medication management technologies. The company designs and manufactures pharmacist-controlled automated prescription medicine dispensing vaults, similar in appearance to ATMs. Intended for deployment in hospitals, pharmacies, medical clinics, and other locations. The company integrates advanced robotics, two-way video teleconferencing, and a secure network for patients medical information to create a...

At Horizon Therapeutics, we believe science and compassion must work together to transform lives. We are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. For us, success is measured by the numbers that matter most – the number of lives we touch, the number we change...

Avicanna is a Canadian international commercial-stage biopharmaceutical company. Focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D and clinical development that has led to the commercialization of more than thirty products across five market segments: MyMedi.ca Medical Cannabis Care Portal, Medical Cannabis & Wellness...

Geneseeq is a research-driven company providing cutting-edge next-generation sequencing (NGS) technology to accelerate precision cancer care. We offer both pan-cancer panels analyzing 400+ genes and cancer-type specific gene panels for all sample types to help match a patient to the optimal treatment, including targeted therapy and immunotherapy. We have 1000+ research projects with biopharma and research partners, providing high-quality genomic...

Pioneering next-gen precision therapeutics for diseases stemming from microtubule dysfunction, such as neuropathies and cardiovascular diseases.

The best anti-aging resource is your own younger cells. Personalized regenerative medicine is the opportunity to leverage strategies that tap into the power of our own cells to treat our bodies. Our cells have the potential to rejuvenate skin, replenish hair, and even help fight disease. Preserving your own cells today can give you access to your own younger cells...